print logo

Contact Our Offices

Clinical Trials

Reset Text Size: A A A

Device Studies

Active Studies

LADDER (Genentech)

A 20 month, phase 2, multicenter, randomized, active treatment-controlled study of the efficacy and safety of the ranibizumab port delivery system for sustained delivery of ranibizumab in patients with subfoveal neovascular age-related macular degeneration.

Completed Studies

CLEAR (DigiSight)

A 3 month, phase 1 and 2 studies on THE CORRELATION OF PAXOS CHECKUP MOBILE APP TO STANDARD IN OFFICE VISUAL ASSESSMENT.